Abstrakt
Pain is among the most common symptoms in patients with pancreatic cancer and up to 80% require analgesics, most often as opioids. Unfortunately the analgesic effect is frequently insufficient, and increasing doses are required, resulting in unpleasant side effects. Endoscopic ultrasound-guided neurolysis is a well established method to alleviate or reduce pain due to pancreatic cancer with a documented effect in 80% of patients. The aim of this review is to draw attention to endoscopic ultrasound-guided neurolysis and to discuss its potential which may not be fully utilized.
Originalsprog | Engelsk |
---|---|
Tidsskrift | Ugeskrift for læger [online] |
Vol/bind | 176 |
Udgave nummer | 50 |
ISSN | 1603-6824 |
Status | Udgivet - 8 dec. 2014 |